UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000024835
Receipt number R000028580
Scientific Title Setting reference value of serum creatinine and serum cystatin C by an enzymatic method in neonates.
Date of disclosure of the study information 2016/11/15
Last modified on 2018/05/29 07:59:47

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Setting reference value of serum creatinine and serum cystatin C by an enzymatic method in neonates.

Acronym

Setting reference value of serum creatinine and cystatin C in neonates.

Scientific Title

Setting reference value of serum creatinine and serum cystatin C by an enzymatic method in neonates.

Scientific Title:Acronym

Setting reference value of serum creatinine and cystatin C in neonates.

Region

Japan


Condition

Condition

normal neonate

Classification by specialty

Nephrology Pediatrics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To establish the reference range of serum creatinine and serum cystatine C by an enzymatic method in neonates.

Basic objectives2

Others

Basic objectives -Others

To establish the reference range of serum creatinine and serum cystatine C by an enzymatic method in neonates.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

serum creatinine and cystatine C at 4 days and a month old

Key secondary outcomes

renal length at a month old


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

1 days-old <=

Age-upper limit

50 days-old >

Gender

Male and Female

Key inclusion criteria

1)normal neonates
-gestational age of more than 37 weeks, less than 42 weeks
-birth weight of more than 2500g, less than 4000g

2) Written informed consent must be obtained from patient's parents

Key exclusion criteria

1) hospitalized in NICU
2) neonatal asphyxia
-Apgar score of less than 7 points
3) oligoamnios
4) solitary kidney
5) judged inappropriate for the clinical trial by doctor

Target sample size

80


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Shunsuke Shinozuka

Organization

National Hospital Organization Saitama National Hospital

Division name

Department of Pediatrics

Zip code


Address

2-1,Suwa,Wako City, Saitama, Japan

TEL

048-462-1101

Email

shino@wakho.hosp.go.jp


Public contact

Name of contact person

1st name
Middle name
Last name Shunsuke Shinozuka

Organization

National Hospital Organization Saitama National Hospital

Division name

Department of Pediatrics

Zip code


Address

2-1,Suwa,Wako City, Saitama, Japan

TEL

048-462-1101

Homepage URL


Email

shino@wakho.hosp.go.jp


Sponsor or person

Institute

National Hospital Organization Saitama National Hospital

Institute

Department

Personal name



Funding Source

Organization

National Hospital Organization Saitama National Hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

National Hospital Organization Tokyo Medical Center
National Hospital Organization Tochigi Medical Center
Fuji Heavy Industries Health Insurance Society Ota Memorial Hospital
Sanokousei General Hospital

Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 11 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 11 Month 10 Day

Date of IRB


Anticipated trial start date

2016 Year 11 Month 15 Day

Last follow-up date


Date of closure to data entry

2018 Year 03 Month 31 Day

Date trial data considered complete

2019 Year 03 Month 31 Day

Date analysis concluded



Other

Other related information

descriptive epidemiology


Management information

Registered date

2016 Year 11 Month 14 Day

Last modified on

2018 Year 05 Month 29 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028580


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name